Richard S. Walsh

Cibiem, Inc. operates as a medical device company. Its catheter-based approach focuses on carotid body modulation for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes, and renal failure. The company was founded by Mark Gelfand and Howard R. Levin and is headquartered in Los Altos, CA.

Coridea NC1, Inc. provides treatment for diastolic heart failure, refractory angina and end-stage renal diseases. The company was founded in 2010 by Howard R. Levin and Mark Gelfand and is headquartered in New York, NY.

Part of Medtronic Plc, Nellcor Puritan Bennett, Inc. is a company that manufactures and supplies respiratory care products. The company is based in Pleasanton, CA. Nellcor Puritan Bennett was acquired by Mallinckrodt, Inc.(Old) on August 26, 1997 for $1,805.05 million.

Respicardia, Inc. is a holding company, which engages in the provision of cardiovascular ultra-sound diagnostic devices. The company was founded by Theodore C. Skokos, Mark Gelfand, Dr. Howard R. Levin and Dr. Danny Sachs in 2006 and is headquartered in Minnetonka, MN.

Coridea LLC develops and manufactures medical devices. The firm provides treatment for diastolic heart failure, refractory angina and end-stage renal diseases. The company was founded by Mark Gelfland and Howard R. Levin in 2003 and is headquartered in New York, NY.

Axon Therapies, Inc. develops treatment for heart failure. The company is headquartered in New York, NY.